SCOTTSDALE, Ariz., June 15, 2011 /PRNewswire/ -- Cayenne Medical, Inc., a private sports medicine device company specializing in the soft tissue reconstruction segment, announces its co-marketing partnership with Parametrics Medical, LLC, a leading provider of high quality bone and tissue allografts, to provide surgeons with tailored knee ligament reconstruction options.
David Springer, CEO of Cayenne Medical, said, “Through this strategic partnership with Parametrics Medical, Cayenne now offers surgeons a comprehensive menu of safe and effective allograft options that compliment Cayenne’s best in class knee implant solutions. The Cayenne Medical sales force will have the unique capability to provide for all of their surgeons’ allograft needs regardless of processing preference, graft type or graft specifications.”
Surgeons utilize allografts in knee ligament reconstruction procedures approximately 40 percent of the time due to preference or specific anatomical requirements. This new alliance will allow Cayenne Medical sales representatives to cater to the specific graft needs of the surgeon, whether he or she is performing a bone-patellar tendon-bone ACL reconstruction using the iFix® PEEK Interference System or a soft tissue allograft reconstruction using Cayenne’s flagship AperFix II® System. The highly trained and clinically-minded staff at Parametrics Medical, combined with the procedure specific expertise and superior implant technology provided by the Cayenne Medical sales force, will deliver an unparalleled blend of service, quality and choice.
“We are pleased to be working with Cayenne Medical to partner our high quality allograft service with their innovative knee ligament repair systems. This relationship is highly synergistic, providing surgeons with the optimal tools and technologies to fit the specific needs of their patients,” said Dan Leary, Vice President and General Manager of Parametrics Medical.
Parametrics Medical, with regional offices in Kalamazoo, MI and Austin, TX, has national contracts with several tissue banking resources throughout the United States that are certified by the American Association of Tissue Banks (AATB) and registered with the Food and Drug Administration (FDA). They offer irradiated grafts, non-irradiated grafts, SuperCritical CO2 non-irradiated grafts, as well as various other bone allografts including freeze-dried, frozen, fresh, and cryopreserved.
Cayenne Medical currently offers products that address previously unmet clinical needs in knee ligament reconstruction and meniscal repair, including the AperFix II® System, CrossFix II® Meniscal Repair System and iFix® System. For more information about Cayenne Medical, please visit www.cayennemedical.com.
About Parametrics Medical, LLC:
Parametrics Medical serves the orthopedic community by providing the very best customer service and the most current technologies in allograft bone and tissue, spanning all specialties within orthopedics to include sports medicine, trauma, reconstructive and spine. By working with reputable tissue banking resources throughout the country, Parametrics Medical’s Preferred Tissue Services is able to provide surgeons with allografts processed and sized to their specifications at a fill rate of nearly 100% with the guaranteed regulation provided by the American Association of Tissue Banks (AATB) and the Food and Drug Administration (FDA). For more information, visit www.parametricsmedical.com.
About Cayenne Medical, Inc.:
Based in Scottsdale, Arizona, Cayenne Medical is a privately held medical device company defining new technology for the soft tissue reconstruction segment of the sports medicine market. The company was founded in 2005 and is focused on leading the transformation of traditional arthroscopic procedures, by applying advanced technology through minimally invasive techniques. For more information, visit www.cayennemedical.com.
Contacts: | Tim Nash | Kimberly Muscara | |
(480) 502-3661 | (646) 536-7011 | ||
tnash@cayennemedical.com | kmuscara@theruthgroup.com | ||
SOURCE Cayenne Medical, Inc.